GlassScriptPhysician profile
Mary Grace Hancock
NPI 1508253295
$4,515.76
in general payments reported to CMS, 2019-2025
42 companies · $726 in 2025
The $726 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $490 · 2021: $842 · 2022: $684 · 2023: $652 · 2024: $764 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101 · Education: $41.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.88 |
| Education | $41.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $755.95 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $533.98 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $521.75 | 2020-2025 | Evenity, Repatha, Repatha |
| Novo Nordisk INC | $342.75 | 2019-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $309.00 | 2019-2025 | |
| Abbvie INC. | $204.74 | 2021-2025 | |
| Lilly USA, LLC | $200.54 | 2019-2024 | Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $187.70 | 2020-2024 | Xifaxan, Trulance |
| Otsuka America Pharmaceutical, INC. | $166.86 | 2023-2025 | Rexulti |
| Cvrx, INC. | $131.82 | 2024 | Barostim Neo System |
| Teva Pharmaceuticals USA, INC. | $115.61 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $101.52 | 2019-2023 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $99.23 | 2022-2025 | |
| Mylan Specialty L.P. | $75.46 | 2022-2023 | Yupelri |
| Axsome Therapeutics, INC. | $56.27 | 2024-2025 | Auvelity |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.